ICD-10 Coding for Nitric Oxide(I27.0, I27.0B, I27.0P)
Explore the ICD-10 coding guidelines for nitric oxide therapy and FeNO testing, including primary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Nitric Oxide
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| I27.0 | Primary pulmonary hypertension | Use when documenting primary pulmonary hypertension requiring nitric oxide therapy. |
|
| P29.3 | Persistent fetal circulation | Use for neonates with persistent fetal circulation treated with inhaled nitric oxide. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNitric Oxide
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Nitric Oxide.
Using FeNO testing codes for COPD diagnosis.
Impact
Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Denial of claims and potential audits.
Mitigation
Use FeNO testing codes only for asthma-related diagnoses.
Missing modifier -25 with E&M codes when billing with CPT 95012.
Impact
Reimbursement: Denial of claims leading to loss of revenue., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of services provided.
Mitigation
Always append modifier -25 to E&M codes when billing with CPT 95012.
Inhaled Nitric Oxide Therapy
Impact
Lack of documentation for oxygenation index and PaO₂ levels.
Mitigation
Ensure all clinical criteria are documented before billing.